ARDS OTC
Aridis Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -92.3%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$29M
-27.0% ▼
Capital Expenditures
$82K
+84.5% ▲
5Y CAGR: -34.8%
Free Cash Flow
-$29M
-24.5% ▼
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$14M
-228.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$22M | -$30M | -$22M | -$42M | -$30M |
| Depreciation & Amort. | $283K | $338K | $337K | $435K | $487K |
| Stock-Based Comp. | $2M | $2M | $2M | $2M | $1M |
| Change in Working Capital | -$3M | $18M | -$617K | $11M | -$1M |
| Other Non-Cash Items | -$2M | $951K | $9K | $7M | $577K |
| Operating Cash Flow | -$24M | -$8M | -$20M | -$23M | -$29M |
| — Investing Activities — | |||||
| Capital Expenditures | -$677K | -$174K | -$367K | -$530K | -$82K |
| Acquisitions (Net) | -$1M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$1M | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2M | -$174K | -$367K | -$530K | -$82K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $715K | $5M | $3M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1M | $0 | $0 | -$4M | $0 |
| Other Financing | $1M | $35K | $14K | $4M | -$1M |
| Financing Cash Flow | $25M | $5M | $9M | $35M | $15M |
| Net Change in Cash | -$859K | -$3M | -$12M | $11M | -$14M |
| Cash End of Period | $24M | $21M | $9M | $20M | $6M |
| Free Cash Flow | -$25M | -$8M | -$21M | -$23M | -$29M |